指南与共识心律失常冠心病

经导管左心耳封堵试验标准化终点定义:LAARC共识

Standardized endpoint definitions for trials of transcatheter left atrial appendage closure: a consensus from the Left Atrial Appendage Academic Research Consortium†.
指南 / 共识 · Eur Heart J · 2026-07-09

左心耳封堵术自2002年问世后,已作为心房颤动高卒中风险患者的抗凝替代疗法快速推广。Left Atrial Appendage Academic Research Consortium联合美国、欧洲、亚洲的学术研究组织、心内科与神经科专家、临床研究者及监管机构,制定LAAC试验标准化研究要素与终点定义。共识提出了死亡、卒中、出血、器械性能及安全性与有效性复合终点的定义,旨在统一终点报告并提升研究间可比性。

要点

  • LAARC共识为LAAC试验提供死亡、卒中、出血和器械性能的统一定义。
  • 共识包含安全性与有效性复合终点,以支持监管和临床试验应用。
  • 标准化终点有助于提高不同LAAC研究之间的可比性。

核心结论

  • LAARC共识旨在标准化左心耳封堵试验的终点报告,提高研究间的可比性。
  • 共识定义的终点可支持LAAC疗法的监管审批和临床试验应用。

研究设计与样本

  • 本共识由Left Atrial Appendage Academic Research Consortium发起,联合美国、欧洲和亚洲的学术研究组织、心内科与神经科专家、临床研究者及监管机构共同制定。
  • 参与监管机构包括美国FDA、欧洲公告机构和日本PMDA。
  • 制定过程考虑了既往Academic Research Consortium倡议、操作与机制见解及临床相关性。

主要发现

  • 共识对死亡、卒中、出血和器械性能提出了标准化定义。
  • 共识提出了安全性和有效性的复合终点。

关键数值与推荐

  • 共识涵盖死亡、卒中、出血和器械性能的定义。
  • 共识涵盖安全性与有效性复合终点的定义。

临床怎么用

  • 通过标准化终点报告,提升LAAC研究的质量和临床实践水平。
  • 标准化定义有助于不同LAAC研究之间的结果比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Since its introduction in 2002, left atrial appendage closure (LAAC) has rapidly expanded as an alternative to anticoagulation in patients with atrial fibrillation at high risk of stroke. Harmonized processes for data collection, analysis, and reporting in LAAC trials are essential to enhance research quality and improve clinical practice. The Left Atrial Appendage Academic Research Consortium (LAARC) initiative is an independent collaboration of academic research organizations, cardiology and neurology experts, clinical trialists, and regulatory authorities from the USA, Europe, and Asia. The consortium engaged clinical experts, regulators-including the US Food and Drug Administration (FDA), European Notified Bodies, and Japan's Pharmaceuticals and Medical Devices Agency (PMDA)-and industry leaders to define standardized study elements and endpoints for LAAC trials. Key considerations included alignment with prior Academic Research Consortium initiatives, procedural and mechanistic insights, and clinical relevance. Consensus definitions were proposed for mortality, stroke, bleeding, and device performance, along with composite endpoints for safety and effectiveness. The proposed LAARC consensus definitions aim to standardize endpoint reporting, improve comparability across studies, and support regulatory and clinical trial applications for this evolving therapy through broad dissemination in the peer-reviewed literature.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Garot, Mehran, de Backer, et al. Standardized endpoint definitions for trials of transcatheter left atrial appendage closure: a consensus from the Left Atrial Appendage Academic Research Consortium†. Eur Heart J. 2026. PMID: 42425446. doi:10.1093/eurheartj/ehag482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。